2. Report by the SC on issues raised by Outreach Forum members during the 4th Outreach Forum meeting in Brussels in June 2014

3. Report by OIE on their activities concerning VMPs since the last VICH Outreach Forum – Strategy phase IV

5. Report from SC discussions on the TFs on concept papers:
5.1. Revision of GL 3(R) on stability to address climatic zones III and IV
5.2. VICH TF for efficacy studies for Combination Products

6. 1st Group Discussion of individual VICH Outreach Forum member questions :
- Waiving TABST vaccines (Introduction by EU)

7. Reporting back to plenary on outcome of 1st group discussions:
Group 2

8. 2nd Group Discussion of individual VICH Outreach Forum member questions : Application of VICH GLs
Introduction by CAMEVET and ASEAN – Mapping - discussion on how VICH GLs can be applied in different regions

9. Reporting back to plenary on outcome of group discussions - Questions/discussions:
Group 2

10.1. ASEAN registration of animal vaccines

10.2. Participation in the VICH process:
How to comment on a draft VICH guideline?

11.1 GLP/GCP: requirement and implementation - EU, China, JMAFF

11.2 Pharmacovigilance: EU/ FDA